3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
79
Neoplasms
9
Carcinoma, Intraductal, Noninfiltrating
5
Breast Neoplasms, Male
4
Neoplasm Metastasis
3
Breast Carcinoma In Situ
3
Arthralgia
3
Triple Negative Breast Neoplasms
2
Sexual Dysfunction, Physiological
1
Seizures
1
Recurrence
1
Pain
1
Osteoporosis
1
Obesity
1
Multiple Endocrine Neoplasia Type 1
1
Lethal Congenital Contracture Syndrome 2
1
Joint Diseases
1
Invasive Breast Cancer
1
Hypogonadism
1
Granulosa Cell Ovarian Cancer
1
Fractures, Bone
1
Erectile Dysfunction
1
Epilepsy
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Metastatic
1
Advanced Metastatic Breast Cancer
1
Advanced Breast Carcinoma
1
Interventions
Cyclophosphamide
13
Doxorubicin
9
Trastuzumab
8
Taxes
7
Paclitaxel
7
Docetaxel
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
Radiotherapy
4
Epirubicin
4
pertuzumab
3
pembrolizumab
3
Melphalan
3
130-nm albumin-bound paclitaxel
3
eribulin
2
Thiotepa
2
Tamoxifen
2
Peripheral Blood Stem Cell Transplantation
2
Lapatinib
2
Fluorouracil
2
Filgrastim
2
Bevacizumab
2
2C4 antibody
2
trastuzumab biosimilar HLX02
1
talimogene laherparepvec
1
sargramostim
1
ruxolitinib
1
romidepsin
1
pegfilgrastim
1
pazopanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Inflammatory Breast Neoplasms
×
Anastrozole
×
Clear all
No trials found.